Log in to search using one of your social media accounts:

 

Bayer halts sales of Essure outside US
Bayer (ETR:BAYN) said today it is halting sales of its Essure contraceptive device outside the US in response to “commercial reasons” and not due to safety or product quality issues. The company said it originally announced it would pull the device from the shelves in most countries in May, and added that it will not resume commercialization in the European Union with no plans to renew its CE Mark. Bayer said it has seen a decline in demand, with a specific drop in France, after the CE Mark for Essure was temporarily suspended in August, according to a French press release. The company went on to again rei...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Women's Health Bayer Source Type: news

Outpatient Hysteroscopy Adequate for Evaluating Postmenopausal Bleeding Outpatient Hysteroscopy Adequate for Evaluating Postmenopausal Bleeding
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Missouri judge slashes 86 plaintiffs from Essure suit against Bayer
A federal judge in Missouri cut 86 of the 94 plaintiffs from a group of consolidated lawsuits filed against Bayer (ETR:BAYN) over its Essure female sterilization device. Essure is a small metal coil that’s placed in the fallopian tubes via catheter. The FDA said in 2015 that it received 5,093 complaints in the 13 years since Essure’s approval, including for pain or menstrual irregularities after using the device and complaints of the device breaking. In addition to five fetal deaths, there were four reports of adult deaths for reasons such as infection and uterine perforation, the FDA&n...
Source: Mass Device - July 17, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Product Liability Women's Health Bayer Source Type: news

Predisposed And Unaware: How Race Called The Shots On My Health
I’m a black woman with uterine fibroids. These noncancerous growths, also called intramural fibroids, line the muscular wall of my uterus. Technically benign, they threaten to grow into larger, painful masses that could ultimately rob me of the ability to bear children. Fibroids are common in all women, but research suggests that African American women are significantly more likely to develop uterine fibroids. In fact, in addition to a family history of fibroids, being African American is at the top of the list of causes for the condition. And black women aren’t only at a higher risk for developing fibroids. Th...
Source: Healthy Living - The Huffington Post - May 15, 2017 Category: Consumer Health News Source Type: news

My hysterectomy and cancer journey – Anya ’ s story
The post My hysterectomy and cancer journey – Anya’s story appeared first on Hysterectomy Association. I had been suffering from heavy bleeding on and off since the birth of my second child in 2012 , medication and the contraceptive pill did nothing to ease the bleeding and I was referred to a gynaecologist, I initially saw a locum gynaecologist who persuaded me to have a Mirena coil fitted. However that made matters matters worse and some six months later following several appointments with another gynaecologist, a hysteroscopy and scans it was discovered that coil had managed to lodge itself in my uterus and ...
Source: The Hysterectomy Association - March 24, 2017 Category: OBGYN Authors: Linda Tags: Your Stories cancer leiomyosarcoma Source Type: news

Femasys Inc. raises $4m
Femasys Inc. said last week that it raised $4 million, according to a regulatory document filed with the SEC. Atlanta-based Femasys wrote that 8 investors contributed to the round and that it paid Los Angeles-based investment bank Salem Partners LLC an estimated $200,000 in sales commissions. The 1st sale in the financing round happened on Jan. 6 this year, the company said in its filing. In December last year, Femasys closed a $40 million Series C round that it said it will use to fund a pivotal trial for its FemBloc permanent female contraception device. The financing round was arranged and led by Salem Partner...
Source: Mass Device - January 17, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Funding Roundup Gynecological Wall Street Beat Women's Health Femasys Inc. Source Type: news

Femasys raises $40m Series C for FemBloc permanent female contraception device
Femasys said earlier this month that it closed on a Series C round worth $40 million it plans to use on a pivotal trial of its FemBloc permanent female contraception device now that it has FDA approval for the study. Atlanta-based Femasys said the round was arranged and led by Los Angeles-based investment bank Salem Partners, with “multiple institutional investors, family offices and a multibillion-dollar global medical device company” also contributing. The company bills FemBloc as a non-surgical procedure that can be performed at the doctor’s office that’s designed to occlude the fallopi...
Source: Mass Device - December 29, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Wall Street Beat Women's Health Femasys Inc. Source Type: news

French women file complaints over complications with Bayer ’ s Essure
Two French women who’ve used Bayer‘s (ETR:BAYN) controversial Essure contraceptive implant have filed a legal complaint alleging similar side-effects to those filed in the U.S. Essure is a small metal coil that’s placed in the fallopian tubes via catheter. The FDA said last year that in the 13 years since Essure’s approval, the agency had received 5,093 complaints, including for pain or menstrual irregularities after using the device, and complaints of the device breaking. In addition to 5 fetal deaths, there were 4 reports of adult deaths for reasons such as infection and uterin...
Source: Mass Device - December 9, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Legal News Women's Health Bayer HealthCare Source Type: news

Better late than never as they say! – Karron ’ s story
The post Better late than never as they say! – Karron’s story appeared first on Hysterectomy Association. I write this story some 6 months after my hysterectomy, I was one of those people that used to pop in and read all the stories, which I must confess really helped me, especially the hints and the special things that would help. So here is my story. Sorry it is late. I presented at A&E this time last year with gallstone pancreatitis seriously ill, at the time the medics found I had a mass in my womb, which I did not know about, I just thought I had a bulky tummy. Turns out my womb was full of fibroids, t...
Source: The Hysterectomy Association - December 8, 2016 Category: OBGYN Authors: Linda Tags: Your Stories fibroids Source Type: news

Expensive IVF add-ons 'not evidence based'
Conclusion  The researchers rightly say "people seeking fertility treatment need good-quality evidence to make informed choices". As the system currently stands, people seek treatment from a variety of private UK fertility clinics. In their desire for a baby, many couples are in a vulnerable situation and rely heavily on the guidance of health professionals. But clinics may offer treatments that aren't sufficiently backed by the evidence. The researchers highlight several problems. The standard first-step recommendation is for people to ask their GP for advice. But GPs are unlikely to have the specialis...
Source: NHS News Feed - November 28, 2016 Category: Consumer Health News Tags: Pregnancy/child QA articles Source Type: news

Essure Labeling Information for Patients and Health Care Providers (Updated)
The original Essure labeling has changed several times since approval in 2002 based on PMA supplements submitted to the FDA and to align with recommendations in the final guidance, Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended... (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - November 18, 2016 Category: Medical Equipment Source Type: news

Smith & Nephew opens $55m plant in Costa Rica
Smith & Nephew (NYSE:SNN) said last week it opened a new $55 million orthopedic device manufacturing facility in Costa Rica. The new facility is expected to add 250 jobs, lifting the employment numbers for the company in the country up to 1,950. “The Government of Costa Rica is pleased to inaugurate the new plant of Smith & Nephew in Coyol, with a capacity to expand the operation by up to 250 new employees. This is the result of the effort of the country to reinforce the conditions to compete and the alliance we have with business and productive sectors. Costa Rica is a stable and growing economy, with low in...
Source: Mass Device - November 1, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Orthopedics Smith & Nephew Source Type: news

FDA recommends new label for Bayer ’ s Essure
The FDA this week released new labeling requirements for Bayer‘s (ETR:BAYN) controversial Essure and other permanent hysteroscopically-placed tubal sterilization implants. Essure is a small metal coil that’s placed in the fallopian tubes via catheter. The FDA said last year that in the 13 years since Essure’s approval, the agency had received 5,093 complaints, including for pain or menstrual irregularities after using the device, and complaints of the device breaking. In addition to 5 fetal deaths, there were 4 reports of adult deaths for reasons such as infection and uterine perforati...
Source: Mass Device - November 1, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Women's Health Bayer HealthCare Source Type: news

Federal Register: Labeling for Permanent Hysteroscopically Placed Tubal Implants Intended for Sterilization; Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA is announcing the availability of the guidance ``Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization.'' This guidance addresses the inclusion of a boxed warning and patient decision checklist in the produc... (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - October 31, 2016 Category: Medical Equipment Source Type: news

Best Way to Prevent Adhesion Formation After Hysteroscopy? Best Way to Prevent Adhesion Formation After Hysteroscopy?
Dr Peter Kovacs reviews the available evidence on prevention of postoperative intrauterine adhesions.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Viewpoint Source Type: news

Hysteroscopy
Title: HysteroscopyCategory: Procedures and TestsCreated: 12/11/2009 12:00:00 AMLast Editorial Review: 8/23/2016 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - August 23, 2016 Category: OBGYN Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 8, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Alere ticks up after reporting delayed 2015 results Shares in Alere ticked up today after the diagnostics giant reported its long-delayed financial results ahead of its $6 billion union with Abbott. Alere, which last month cut ...
Source: Mass Device - August 8, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Smith & Nephew closes $350m Truclear sale to Medtronic, launches $300m buyback
Smith & Nephew (NYSE:SNN) said today that it closed the $350 million sale of its gynecology business, including the Truclear hysteroscopy system, to Medtronic (NYSE:MDT). The London-based healthcare giant also made good on its promise to put $300 million of the proceeds toward a stock buyback plan. Smith & Nephew has said it expects most of the gynecology unit’s employees to join Medtronic after the deal, which was announced in May. The Truclear device put up sales of $56 million last year, or just more than 1% of SNN’s total revenues; the company said said in May that...
Source: Mass Device - August 8, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Mergers & Acquisitions Wall Street Beat Women's Health Medtronic Smith & Nephew Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 18, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Teleflex closes $400m debt offering Teleflex said Monday it closed a $400 million debt offering round through the offering of 4.875% senior notes due in 2026. The Wayne, Penn.-based company said it expects to net approximately ...
Source: Mass Device - May 18, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Smith & Nephew deals Truclear gynecology biz to Medtronic for $350m
Smith & Nephew (NYSE:SNN) said today that it’s dealing its gynecology business to Medtronic (NYSE:MDT), including the Truclear hysteroscopic resection and removal system, for $350 million. The London-based healthcare giant said the Truclear device put up sales of $56 million last year, or just more than 1% of total revenues. The proceeds will go toward a $300 million stock buyback, Smith & Nephew said. “Smith & Nephew’s management team has a strong track record of creating value through organic growth and by acquisition. The sale of our gynecology business demonstrates our disci...
Source: Mass Device - May 18, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Mergers & Acquisitions Wall Street Beat Women's Health Medtronic Smith & Nephew Source Type: news

Routine Hysteroscopy Before IVF Does Not Improve Live Birth Rates (FREE)
By Amy Orciari Herman Edited by André Sofair, MD, MPH Hysteroscopy should not be performed routinely before in vitro fertilization, according to two European studies reported in the Lancet.In the first, 750 women scheduled for their first IVF cycle who had a normal … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 28, 2016 Category: Primary Care Source Type: news

New "See-and-Treat" Truclear(TM) Hysteroscope Improves Options for Office Hysteroscopy
LONDON, March 9, 2016 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announced the launch of the TRUCLEAR 5C Hysteroscope Set for the combined diagnosis and removal of abnorm... Devices, Product LaunchSmith & Nephew, TRUCLEAR, Hysteroscope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 9, 2016 Category: Pharmaceuticals Source Type: news

Federal Register: Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization, Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA is announcing the availability of the draft guidance entitled "Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization." This draft guidance addresses the inclusion of a boxed warning and a patient decision... (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - March 4, 2016 Category: Medical Equipment Source Type: news

Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization - Draft Guidance for Industry and Food and Drug Administration Staff
This draft guidance identifies content and format for labeling materials for permanent, hysteroscopically-placed tubal implant devices intended for female sterilization. FDA believes this guidance, when finalized, will help to ensure that a woman... (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - February 29, 2016 Category: Medical Equipment Source Type: news

Shell shocked after complex atypical hyperplasia diagnosis – Liz’s story
The post Shell shocked after complex atypical hyperplasia diagnosis – Liz’s story appeared first on Hysterectomy Association. Sorry that this story of mine is so long but so much has happened all interlinked with each other I felt it is all important and might be useful to someone else in similar circumstances. At the beginning of this year after 3 years of no periods I had a couple of small bleeds lasting at most 2 days, shortly after I had an acute chest infection requiring large doses of antibiotics. At a follow up visit re this at my GP surgery I asked if I would be able to have the steroid injection in my ...
Source: The Hysterectomy Association - December 2, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories Complex Atypical Hyperplasia Source Type: news

Shell shocked after complex atypical hyperplasia diagnosis – Liz ’ s story
The post Shell shocked after complex atypical hyperplasia diagnosis – Liz’s story appeared first on Hysterectomy Association. Sorry that this story of mine is so long but so much has happened all interlinked with each other I felt it is all important and might be useful to someone else in similar circumstances. At the beginning of this year after 3 years of no periods I had a couple of small bleeds lasting at most 2 days, shortly after I had an acute chest infection requiring large doses of antibiotics. At a follow up visit re this at my GP surgery I asked if I would be able to have the steroid injection in my ...
Source: The Hysterectomy Association - December 2, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories Complex Atypical Hyperplasia Source Type: news

Essure Contraceptive Implant Tied to Higher Reoperation Rates Essure Contraceptive Implant Tied to Higher Reoperation Rates
A study comparing implant-based hysteroscopic sterilization with laparoscopic sterilization has found that implant failure or migration increased risk for reoperation within 1 year of the procedure. Medscape Medical News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - October 15, 2015 Category: OBGYN Tags: Ob/Gyn & Women ' s Health News Source Type: news

Essure Sterilization Device Linked to Greater Need for Reoperation (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD Hysteroscopic sterilization with the Essure implant, compared with more traditional laparoscopic sterilization, is associated with a 10-fold increase in the need for reoperation within 1 year, a BMJ … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 15, 2015 Category: Primary Care Source Type: news

Essure sterilisation implant has 'high risk' of complications
ConclusionThe results of this study seem clear: women undergoing hysteroscopic sterilisation are more likely to need a repeat operation than women undergoing the standard laparoscopic sterilisation. However, we don’t know why.The study indicates that women having the newer procedure may have a higher risk of complications because of their age, and previous problems such as pelvic inflammatory disease. Although the researchers took these issues into account, they may have missed other factors contributing to the results. One additional factor is that all women undergoing a hysteroscopy have a standard check three mont...
Source: NHS News Feed - October 14, 2015 Category: Consumer Health News Tags: Medical practice Pregnancy/child Source Type: news

Five-Year Follow-Up Study Further Supports Effectiveness And Safety Of The Essure&Reg; Procedure As A Non-Surgical, Non-Hormonal Option For Permanent Contraception
Bayer HealthCare announced today that a study published online this week in The Journal of Minimally Invasive Gynecology reinforces findings from previous clinical studies that support the effectiveness and safety of the Essure® inserts and procedure for hysteroscopic sterilization, or permanent birth control. (Source: Medical Design Online News)
Source: Medical Design Online News - May 5, 2015 Category: Medical Equipment Source Type: news

No “best” treatment for common uterine fibroids
The other night, I sat in a restaurant with a group of girlfriends. We shared laughter, good conversation and some great wine. As I looked around, I realized that we were likely to share something else: uterine fibroids. Of the ten women sitting at the table, there was a good chance that seven of us would have uterine fibroids at some point in our lives. Fibroids are noncancerous tumors that grow in the uterus. They may be smaller than a seed or bigger than a grapefruit. A woman may have only one fibroid or she may have many. Depending on their size, number, and location, fibroids can cause heavy bleeding and long menstrua...
Source: New Harvard Health Information - April 23, 2015 Category: Consumer Health News Authors: Urmila Parlikar Tags: Women's Health fibroids uterine fibroids Source Type: news

Complex Hyperplasia with Atypia – Reethah’s Story
Sourced from The Hysterectomy Association: Hysterectomy Association - Hysterectomy Association - hysterectomy, menopause and hormone replacement therapy (hrt) information and support for women. My story took off in October 2013 during an appointment with my doctor for something else entirely unconnected – eczema behind the ears. A chance mention in passing to my doctor that I had had an unexpected period the month before after a long gap caused her to prick up her ears. When was your last period before that? she enquired. I looked back at my diary where I log all my periods and body changes. I knew it had been more t...
Source: The Hysterectomy Association - February 23, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories Complex Hyperplasia with Atypia endometrial cancer Source Type: news

First U.S. Procedures Completed With The Symphion(TM) Hysteroscopic Tissue Removal System
MARLBOROUGH, Mass., Nov. 17, 2014 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) announces the completion of the first U.S. procedures performed with the Symphion System, designed for the hysteroscopic removal of interute... Devices, Product LaunchBoston Scientific, Symphion, hysteroscope, hysteroscopic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2014 Category: Pharmaceuticals Source Type: news

Hysteroscopic Morcellation of Fibroids – NICE Research
Sourced from The Hysterectomy Association: Hysterectomy Association - Hysterectomy Association - hysterectomy, menopause and hormone replacement therapy (hrt) information and support for women. What is hysteroscopic morcellation of uterine leiomyomas (fibroids)? NICE is looking at a very specific type of procedure which is called ‘hysteroscopic morcellation of uterine leiomyomas (fibroids). In this procedure, a small metal tube (a hysteroscope) is put inserted through the vagina and into the womb through the cervix. A small instrument with a specially designed tip is inserted through the tube and used to break the fi...
Source: The Hysterectomy Association - October 20, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Research fibroids morcellation Source Type: news

Minimally Invasive Uterine and Fibroid Morcellation Warnings
Sourced from The Hysterectomy Association: Hysterectomy Association - Hysterectomy Association - hysterectomy, menopause and hormone replacement therapy (hrt) information and support for women. In recent months there have been a number of warnings issued about uterine polyp and fibroid morcellation during laparascopic hysterectomy or myomectomy, most notably by the FDA in the United States. It’s come about because in a small number of cases the fibroids being removed were shown to be malignant after the surgery, something that was not known prior to the operation. In a few of these cases women went on to develop leio...
Source: The Hysterectomy Association - September 22, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Alternatives to Hysterectomy laparascopic hysterectomy morcellation myomectomy Source Type: news

The Forty Year Wait – Andi’s Story
Sourced from The Hysterectomy Association: Hysterectomy Association - Hysterectomy Association - hysterectomy, menopause and hormone replacement therapy (hrt) information and support for women. Every since I was 11 years old I had terrible periods. My mother used to sit me on the lawn with a towel and told me only to come inside when the towel needed changing. When I talk about a towel I mean a bath towel – not a sanitary napkin!! Eventually I was taken to the doctor and despite my mothers support the doctor always said it was “in my head”, so all my growing up years I was plagued with these terrible peri...
Source: The Hysterectomy Association - August 30, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories endometrial ablation fibroids laparascopic hysterectomy Source Type: news

Thank goodness I went to GP!! – Joy’s Story
Hi all. I started off the year badly! I slipped over on a slimey wet path onto my front & badly bruised & battered myself, this was in February 2014! In March I had an itchy clear discharge, firstly I thought it was thrush, & treated accordingly. But still it continued! I made an appointment to see my GP for the following week. Believe it or not on the day, of my GP appointment the discharge became blood stained, I may not have mentioned it otherwise! As I’m 3 years post menopause my GP fast tracked me to the local hospital! So in April I had an appointment for an ultrasound in the morning & hysterosc...
Source: The Hysterectomy Association - August 8, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Women's Health cancer Source Type: news

Women given pointless and expensive checks before IVF, warn doctors
A study at London's Guy's and St Thomas's found that having a hysteroscopy to check the womb before fertility treatment makes no difference to success rates. (Source: the Mail online | Health)
Source: the Mail online | Health - June 30, 2014 Category: Consumer Health News Source Type: news

Efficacy doubts over pre-IVF hysteroscopy
A large multicenter trial seems finally to have resolved one of IVF's long-running controversies -- whether the outlook for women with a poor IVF record can be improved by routine hysteroscopy performed before further IVF treatment. Only around 1/3 of IVF cycles achieve a pregnancy, and unsuccessful attempts can usually be explained by embryonic or uterine factors. As a result, hysteroscopy is performed in many clinics before further attempts to visualize the surface of the uterus and operatively remove any abnormal growths if found. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 30, 2014 Category: Science Source Type: news

Efficacy doubts over pre-IVF hysteroscopy
(European Society of Human Reproduction and Embryology) A large multicenter trial seems finally to have resolved one of IVF's long-running controversies -- whether the outlook for women with a poor IVF record can be improved by routine hysteroscopy performed before further IVF treatment. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 30, 2014 Category: Biology Source Type: news

Not Prepared For Hysterectomy – Jan’s Story
Hi everyone. My name is Jan and I had a hysterectomy in 2014. Since 1998 I had a history of abnormal cervical smears which were treated in different ways many times. During that period I also had VAIN 2 pre-cancerous cells in the vagina. I have had bleeding in the urine from sept 2013 and was told it was looking like bladder cancer and was kept in hospital and underwent several tests. It wasn’t thank God. no reason for bleed given. Then as I still had abdominal pain and a history of ovarian cancer with grandmother they investigated me for possible ovarian cancer. Transvaginal scan ok and ultrasound fine. Then they in...
Source: The Hysterectomy Association - June 23, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories adhesions total abdominal hysterectomy uterine cancer Source Type: news

Tubal Ligation and Resection
Tubal Ligation by Parkland and Irving Methods Parkland tubal ligation Parkland Tubal Ligation The Parkland tubal ligation technique falls into the category of tubal ligation and resection. The Parkland procedure involves tying two non-absorbable ligatures around the fallopian tube in its proximal to middle segment and then cutting out the tubal segment between the ligatures. The end result is similar to the Pomeroy method of tubal ligation. Two healthy tubal segments remain that can be rejoined by tubal reversal microsurgery. Two-thirds of women with a Parkland tubal ligation become pregnant following tubal reversal surger...
Source: Tubal Ligation Reversal News - April 29, 2014 Category: Reproduction Medicine Authors: tube Tags: Uncategorized Source Type: news

Tubal Ligation – Fimbriectomy
Tubal Reversal is Possible after Fimbriectomy Fimbriectomy tubal ligation Fimbriectomy Tubal ligation by fimbriectomy involves removing a portion (usually up to one-third) of the fallopian tube closest to the ovary. With microsurgical techniques, the end of the remaining fallopian tube can be opened and the inner tubal lining gently folded outward over the cuff to improve the chances of egg capture. This tubal reversal procedure is called microsurgical salpingostomy. Reversing Fimbriectomy tubal ligation Final Result It is generally thought that tubal reversal cannot be successful following a fimbriectomy because of the lo...
Source: Tubal Ligation Reversal News - April 29, 2014 Category: Reproduction Medicine Authors: tube Tags: Uncategorized Source Type: news

Tubal Ligation – Fimbriectomy
Tubal Reversal is Possible after Fimbriectomy Fimbriectomy tubal ligation Fimbriectomy Tubal ligation by fimbriectomy involves removing a portion (usually up to one-third) of the fallopian tube closest to the ovary. With microsurgical techniques, the end of the remaining fallopian tube can be opened and the inner tubal lining gently folded outward over the cuff to improve the chances of egg capture. This tubal reversal procedure is called microsurgical salpingostomy. Reversing Fimbriectomy tubal ligation Final Result It is generally thought that tubal reversal cannot be successful following a fimbriectomy because of the lo...
Source: Tubal Ligation Reversal News - April 29, 2014 Category: Reproduction Medicine Authors: Dr. Monteith Tags: Uncategorized Source Type: news

Essure and Adiana Tubal Sterilization
Essure and Adiana are hysteroscopic sterilization methods that block the fallopian tube. Essure Sterilization Procedure Essure sterilization is a new hysteroscopic tubal occlusion method that became approved for use in the United States in November 2002. Essure is a coiled spring device that is inserted through the uterine cavity into the tubal openings using a hysteroscope. This can be done as an office procedure. The Essure micro-insert consists of a stainless steel inner coil, a super-elastic outer coil, and polyethylene fibers wound in and around the inner coil. When released, the outer coil expands to anchor the micro...
Source: Tubal Ligation Reversal News - April 29, 2014 Category: Reproduction Medicine Authors: tube Tags: Uncategorized Source Type: news

Tubal Ligation – Tubal Ring or Clip
Tubal Ligation with Tubal Rings or Tubal Clips Tubal rings and tubal clips are mechanical methods of tubal ligation applied to the fallopian tubes through a laparoscope. Tubal rings and clips damage minimal lengths of the fallopian tube and are ideal for tubal reversal. Tubal ligation with tubal rings Tubal Ring The tubal ring (also called the Falope ring, Yoon ring, or Lay loop) is a small silastic band placed around a loop of the fallopian tube. With this method of tubal ligation, a 2-3 cm segment of fallopian tube is drawn inside a narrow cone-shaped applicator. The silastic ring (that previously has been stretched over...
Source: Tubal Ligation Reversal News - April 29, 2014 Category: Reproduction Medicine Authors: tube Tags: Uncategorized Source Type: news

Tubal Ligation – Tubal Ring or Clip
Tubal Ligation with Tubal Rings or Tubal Clips Tubal rings and tubal clips are mechanical methods of tubal ligation applied to the fallopian tubes through a laparoscope. Tubal rings and clips damage minimal lengths of the fallopian tube and are ideal for tubal reversal. Tubal ligation with tubal rings Tubal Ring The tubal ring (also called the Falope ring, Yoon ring, or Lay loop) is a small silastic band placed around a loop of the fallopian tube. With this method of tubal ligation, a 2-3 cm segment of fallopian tube is drawn inside a narrow cone-shaped applicator. The silastic ring (that previously has been stretched over...
Source: Tubal Ligation Reversal News - April 29, 2014 Category: Reproduction Medicine Authors: Dr. Monteith Tags: Uncategorized Source Type: news

Tubal Ligation – Pomeroy Technique
Pomeroy Tubal Ligation and Resection Pomeroy Tubal Ligation Tubal ligation and resection (removal) of a portion of the fallopian tube is the most frequent method of blocking the tubes. This involves tying a segment of tube and removing it. There are many variations of this technique. The tubal ligation procedure described by Dr. Ralph Pomeroy a century ago is most commonly used today. With the Pomeroy method of tubal ligation, part of the tube is elevated to create a loop or knuckle (top picture). An absorbable ligature is tied around the base of the elevated segment, and the tubal segment is cut out (middle picture). Tie...
Source: Tubal Ligation Reversal News - April 29, 2014 Category: Reproduction Medicine Authors: tube Tags: Uncategorized Source Type: news

Tubal Ligation – Pomeroy Technique
Pomeroy Tubal Ligation and Resection Pomeroy Tubal Ligation Tubal ligation and resection (removal) of a portion of the fallopian tube is the most frequent method of blocking the tubes. This involves tying a segment of tube and removing it. There are many variations of this technique. The tubal ligation procedure described by Dr. Ralph Pomeroy a century ago is most commonly used today. With the Pomeroy method of tubal ligation, part of the tube is elevated to create a loop or knuckle (top picture). An absorbable ligature is tied around the base of the elevated segment, and the tubal segment is cut out (middle picture). Tie...
Source: Tubal Ligation Reversal News - April 29, 2014 Category: Reproduction Medicine Authors: Dr. Monteith Tags: Uncategorized Source Type: news